ClinicalTrials.Veeva

Menu

Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone

A

Atrium Medical Center

Status

Unknown

Conditions

Abortion, Induced

Treatments

Drug: misoprostol
Drug: sulprostone
Drug: mifepristone

Study type

Observational

Funder types

Other

Identifiers

NCT00206193
TOP-protocol

Details and patient eligibility

About

The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women by whom a termination of pregnancy is desired.

Exclusion criteria

  • Women with liver/kidney disease
  • Women on long-term use of corticosteroids (> 6 months)
  • Cardiovascular problems
  • Therapy-resistant diabetic women
  • Therapy-resistant asthma/bronchitis
  • Thalassemia
  • Ulcerative colitis
  • Peptic ulcer disease
  • Glaucoma
  • Porphyria
  • Allergic reaction to prostaglandin or mifepristone
  • Women with a prior caesarian section or women with contractions at the start of the study

Trial contacts and locations

1

Loading...

Central trial contact

Suzanne HW Vonken, Dr.; F Roumen, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems